| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 11/25/2004 | US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 11/24/2004 | EP1478640A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 11/24/2004 | EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 11/24/2004 | CN1176917C Prep. of pyrone compound |
| 11/23/2004 | US6821963 4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors |
| 11/18/2004 | WO2004099132A2 Process for the preparation of trans-isomers of diphenylazetidinone derivatives |
| 11/18/2004 | WO2004098582A2 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 11/18/2004 | US20040229924 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/TACE inhibitors |
| 11/18/2004 | US20040229915 Cysteine protease inhibitors |
| 11/17/2004 | EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 11/17/2004 | EP1476416A2 Multifunctional monomers and their use in making cross-linked polymers and porous films |
| 11/17/2004 | EP1210333B1 p-Tolyl-heterocycles as herbicides |
| 11/17/2004 | EP1165538B1 Process for the preparation of alpha-methylenelactones and alpha-substituted hydrocarbylidene lactones |
| 11/16/2004 | US6818789 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one |
| 11/16/2004 | US6818775 Treatment of skin-related diseases or prevention of certain undesired side effects of administered retinoids |
| 11/11/2004 | WO2004096789A1 Method of preparing statins intermediates |
| 11/11/2004 | WO2004096788A1 Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof |
| 11/11/2004 | WO2004085344A3 Production of oxy-michael adducts |
| 11/11/2004 | WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 11/11/2004 | US20040224990 Enantioselective hydrogenation of intermediates in the synthesis of tipranavir |
| 11/11/2004 | US20040224960 Pharmaceutical compositions and methods for their use |
| 11/11/2004 | US20040224959 such as N-benzyl-3-[4-(3,3-diphenyl-1-propyl)piperazin-1-yl]-N-methylbenzamide; for inhibition of secretion of apolipoprotein B lipoprotein from the liver; for treatment of hyperlipidemia, pancreatitis |
| 11/11/2004 | US20040224904 Carbohydrate scaffold, carrying two side chains, which form a macrocyclic ring that may be unsaturated and contains ether, amide, ester and/or carbamate groups; for therapy of bacterial, fungal, viral or protozoal infections or tumors |
| 11/11/2004 | CA2524457A1 Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof |
| 11/10/2004 | EP1475371A1 1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 11/10/2004 | EP1474411A2 Improved process for the production of dihydropyridines |
| 11/10/2004 | EP1474098A1 Sunscreen compositions as well as dihydropyridines and dihydropyranes |
| 11/10/2004 | CN1174974C Synthesis of ester ether compound with high acidolysis activity |
| 11/04/2004 | WO2004094412A1 Nk-2 antagonist basic linear compounds and formulations containing them |
| 11/04/2004 | WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use |
| 11/04/2004 | CA2523200A1 Nk-2 antagonist basic linear compounds and formulations containing them |
| 11/03/2004 | EP1473291A1 Process for producing lactone |
| 11/03/2004 | EP1473275A1 Metallized mesoporous silicate and method of oxidation with the same |
| 11/03/2004 | EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 11/03/2004 | CN1543468A Processes for preparing calcium salt forms of statins |
| 11/03/2004 | CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 11/03/2004 | CN1173913C Method of using easy removed nitroxyl selective alcohol axide |
| 11/02/2004 | US6812227 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 10/28/2004 | US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal |
| 10/28/2004 | US20040214887 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy |
| 10/28/2004 | US20040213442 Novel fatty acids analogous |
| 10/27/2004 | EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 10/27/2004 | EP1470143A1 Compounds that inhibit factor xa activity |
| 10/27/2004 | EP1470118A1 Alpha-methylenelactone synthesis in supercritical fluids |
| 10/27/2004 | EP1470104A2 Novel compounds that inhibit factor xa activity |
| 10/27/2004 | EP1469851A1 Melanocortin receptor agonists |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | CN1541096A Compounds which mimic chemical and biological properties of discodermolide |
| 10/27/2004 | CN1539825A Compounds useful to treat retroviral infections |
| 10/26/2004 | US6809223 Process for stereoselective synthesis of prostacyclin derivatives |
| 10/26/2004 | US6809207 Amino acid derivatives |
| 10/21/2004 | WO2004089926A2 Genipin derivatives and uses thereof |
| 10/21/2004 | WO2004089868A1 Amorphous simvastatin calcium and methods for the preparation thereof |
| 10/21/2004 | US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 10/21/2004 | US20040209847 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders |
| 10/21/2004 | CA2521095A1 Amorphous simvastatin calcium and methods for the preparation thereof |
| 10/20/2004 | EP1467726A2 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 10/20/2004 | CN1538964A Substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 10/20/2004 | CN1171866C Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 10/19/2004 | US6806264 Arylphenyl-substituted cyclic ketoenols |
| 10/14/2004 | WO2004087852A1 PERFUME COMPOSITIONS AND 3,6-DICYCLOPENTYL-δ-VALERO- LACTONE |
| 10/14/2004 | WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca) |
| 10/14/2004 | US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen |
| 10/14/2004 | US20040204594 S-(+)-4-Methoxy-6-phenethyl-5,6-dihydro-pyran-2-one; plant extracts for nutraceutical foods, topical ointments |
| 10/14/2004 | US20040204502 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 10/14/2004 | US20040203119 synthase (PKS) system, comprising at least two modules, of said PKS, wherein said PKS has been modified to prevent its utilization of its native starter unit, but wherein said PKS is able to incorporate a diketide substrate into a polyketide that is at least a triketide |
| 10/13/2004 | EP1466899A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
| 10/13/2004 | EP1466886A2 New salts of HMG-CoA reductase inhibitors |
| 10/13/2004 | EP1466590A1 Cosmetic use of new desquamative agents |
| 10/13/2004 | EP1277750B1 Hydrates and crystals of a neuraminic acid compound |
| 10/13/2004 | EP0848712B1 Dihydropyran derivatives as viral neuraminidase inhibitors |
| 10/13/2004 | CN1535956A Substituted phenyl keto-enol pesticide and weedicide |
| 10/07/2004 | WO2004085427A1 Enantioselective hydrogenation of intermediates during tipranavir synthesis |
| 10/07/2004 | WO2004085344A2 Production of oxy-michael adducts |
| 10/07/2004 | US20040198814 prevention , therapy of cardiovascular disorders, dyslipidemias, glucose metabolism, hypoglycemic agents; reduce fat concentration in meat; reduce cholesterol concentration in eggs |
| 10/07/2004 | DE10313118A1 Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese Enantioselective hydrogenation of intermediates in the synthesis of tipranavir |
| 10/07/2004 | CA2520129A1 Enantioselective hydrogenation of intermediates in the synthesis of tipranavir |
| 10/06/2004 | EP1463820A1 Method of screening compounds |
| 10/06/2004 | EP1463723A1 Process for the preparation of simvastatin |
| 10/06/2004 | EP1101755B1 Anthranilic acid derivatives |
| 10/06/2004 | CN1535145A Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors |
| 10/05/2004 | US6800646 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 10/05/2004 | US6800612 Have vasodilating activity and inhibit the aggregation of the platelets; releasing no |
| 09/30/2004 | WO2004082682A1 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/30/2004 | WO2004052831A3 Method for the production of optically active dihydropyrones |
| 09/30/2004 | US20040192771 Cerdiovascular disorders; antilipemic agents; alzheimer's disease; anticancer agents; sepsis; thrombosis; hypotensive agents; kidney diseases; antiinflammatory agents |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | CA2519220A1 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/29/2004 | EP0993439B1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 09/28/2004 | US6797831 Process for lactonization to produce simvastatin |
| 09/28/2004 | US6797721 Contacting the cancer cell with a phorboxazole derivative to inhibit growth of cancer cells, induction of apoptosis and inhibition of metastises |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/23/2004 | WO2004080990A1 C-glycoside derivatives and salts thereof |
| 09/23/2004 | WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols |
| 09/23/2004 | WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | WO2004043884A3 Novel acylating reagents |
| 09/23/2004 | WO2004030684A3 Kavalactone product |